Our clinical trials will evaluate the efficacy of prioritised repurposed drugs as promising disease-modifying treatments for Parkinson’s disease. These drugs have been shortlisted by the Cure Parkinson’s Trust Linked Clinical Trials (LCT) program and have been rigorously evaluated for their potential to slow or halt the progression of the disease. 

Phase II clinical trials will be conducted at major Queensland hospitals and clinical research centres. We will be recruiting at multiple clinical trial sites from across Queensland including:

  • Royal Brisbane Hospital and UQ Centre for Clinical Research (UQCCR)
  • Wesley Hospital and Wesley Medical Research  
  • Gold Coast University Hospital and Griffith Health Centre

Please contact our clinical trials team if you are a person with Parkinson’s disease and are interested in participating in our clinical trials.

Senior Clinical Trials Coordinator
Elisabeth Arnold
Email: qdri.research@uq.edu.au

Clinical Trials Coordinator
Helen Woodhouse
Email: qdri.research@uq.edu.au
Tel: 07 3346 5043